Close Menu

Associate Director, Genetic Epidemiology - Cardiovascular, Metabolic, Musculoskeletal Diseases (Regeneron Genetics Center)

Organization
Regeneron Pharmaceuticals
Job Location
777 Old Saw Mill River Road
Tarrytown, NY 10591
United States
Salary
Commensurate to experience
Benefits
  • Comprehensive medical, dental, vision benefits
  • Relocation benefits (if eligible)
  • 401k match
  • 18 PTOs + winter shutdown (Christmas to New Year)
  • Tution reimburesement
Job Description

Position SummaryThe Regeneron Genetics Center (RGC) is a wholly-owned subsidiary of the Company, whose goals are to apply large scale human genetics to identify new drug targets and to guide the development of therapeutics programs and precision medicine. Building upon Regeneron's strengths in mouse genetics and genetics-driven drug discovery and development, the RGC specializes in ultra-high-throughput exome sequencing, large scale informatics and data analysis encompassing genomics and electronic health records, and translating genetic discoveries into new biology and drug discovery opportunities. The RGC leverages multiple approaches including large population based studies, Mendelian genetics and family based studies, founder population genetics, and large-scale disease focused projects and has developed a network of over 50 collaborations with research organizations around the world. Including some of the largest sequencing studies in the world, such as the DiscovEHR study in collaboration with Geisinger Health System, and an initiative to sequence 500,000 participants with the UK Biobank, the RGC has built one of the largest human genetics databases, including sequence data from over several hundred thousand participants and rapidly growing. Our interests encompass a breadth of different areas across all therapeutic areas and the RGC is highly integrated into all facets of research and development at Regeneron. Program goals include target discovery, indication discovery, and patient-disease stratification. Objectives include advancing basic science around the world through public sharing of discoveries, providing clinically-valuable insights to physicians and providers of collaborating health-care systems, improving patient outcomes, and identifying novel targets for drug development.

Summary:
We are looking for a talented Genetic Epidemiologist with strong quantitative skills to join our Cardiovascular, Metabolic and Musculoskeletal Therapeutic Area Genetics team. The post holder will have key responsibilities in mining large human genetics datasets including 100,000s of genotyped and sequenced participants, in partnership with other RGC teams, to translate genetic findings into new therapeutic insights. 

The key goals of the post will be (a) to empower the translation of genetic association findings into new therapeutic targets, indications and precision medicine approaches that will enable Regeneron to deliver better medicines to the patients who need them in the fields of Cardiovascular, Metabolic and Musculoskeletal Medicine; (b) to support existing pre-clinical and clinical development programs within Regeneron in these Therapeutic Areas using human genetics approaches; (c) to form strong partnerships with the Analytical Genomics, Clinical Informatics, other RGC’s teams to accomplish the goals of the Therapeutic Area Genetics team, RGC and Regeneron at large.

Responsibilities:
• Design and execute complex analyses across datasets to accomplish the translational goals of the Therapeutic Area Genetics team.
• Work in close collaboration with other Therapeutic Area Genetics team members and form a strong partnership with Analytical Genomics, Clinical Informatics and other RGC teams to deliver on complex, top-quality scientific endeavours in these Therapeutic Areas.
• Generate, summarise, and present results in internal and external meetings to a variety of audiences. Lead or contribute to the writing of scientific reports and publications.
• Represent the Therapeutic Area Genetics team in cross-functional initiatives within RGC and Regeneron.
• Collaborate with external industry and academic partners in scientific consortia.

Requirements

• PhD in Genetic Epidemiology, Statistical Genetics (with an applied focus), Human Genetics or similar and strong quantitative and analytical skills.
• 5+ years of experience and/or an outstanding level of achievement in the field of large-scale human genetics post PhD. 
• Expertise in the genome-wide and gene-centric analysis of large human genetics datasets for translational insights. The successful candidate will use (a) Mendelian randomization to elucidate causal mechanisms and evaluate whether pharmacological treatment of a target is likely to be effective and safe; (b) polygenic risk scores to enhance etiologic understanding and genetic prediction, (c) fine-mapping and other prioritization approaches to identify causal variants and genes underlying genetic association signals and (d) will routinely combine information across multiple traits, variants and data sources to generate new insights. An outstanding candidate will have contributed to the application of these methods to important biological problems in the field of Cardiovascular, Metabolic and Musculoskeletal Medicine.
• Expertise with modern cluster and cloud computing environments and with statistical analysis software (R environment for statistical computing, STATA) and human genetics analysis tools (METAL, GCTA, PLINK or similar). 
• Interest in understanding the genetic basis of Cardiovascular, Metabolic and Musculoskeletal diseases and translating this knowledge into therapeutic insights. An outstanding candidate will have previously worked on cardiovascular, metabolic or musculoskeletal phenotypes.
• Ability to work in a highly interactive environment with a diverse team of colleagues. Ability to provide mentorship and guidance to more junior colleagues to help them develop their full potential and build new skills and abilities. 
• Outstanding communication skills and an ability to summarize and present the results of human genetic studies to a variety of technical audiences, ranging from experts in statistical genetics, human genetics, biology, drug design and medicine.
• A commitment to high-quality science and to the highest standards of research and work ethics and integrity.

How to Apply

Regeneron is a place where possibilities are limitless, where the science is energizing and informs every decision, where innovation and collaboration are the very core of our culture, and where our primary focus is to make a difference in patients’ lives.

Considering this opportunity? Please submit your application online. Qualified applicants will be contacted immediately. 

https://careers.regeneron.com/job/REGEA002617468BR5080/Associate-Directo...

Regeneron is an equal opportunity employer and all qualified applicants will receive consideration for employment without regard to race, color, religion, sex, national origin, sexual orientation, gender identity, disability status, protected veteran status, or any other characteristic protected by law.

About Our Organization

Known for its scientific and operational excellence, Regeneron is a leading science-based biopharmaceutical company that discovers, invents, develops, manufactures, and commercializes medicines for the treatment of serious medical conditions. Regeneron commercializes medicines for eye diseases, high LDL-cholesterol, atopic dermatitis and a rare inflammatory condition and has product candidates in development in other areas of high unmet medical need, including rheumatoid arthritis, asthma, pain, cancer and infectious diseases.

A new study finds that a positive lab environment can encourage undergraduates to continue to perform research.

A new analysis suggests non-US citizen STEM PhDs might pass up jobs at US-based startups due to visa concerns.

A UK survey of researchers who identified as LGBT+ and allies uncovered evidence of unwelcoming workplace climates in the physical sciences.

At the Guardian, the University of Edinburgh's Nikolay Ogryzko argues that universities need to better invest in postdocs' careers.